- Home
- OABI vs KNOP Comparison
OABI vs KNOP Comparison
Compare OABI & KNOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OABI | KNOP |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | United Kingdom |
| Employees | 114 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 300.9M | 346.6M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | OABI | KNOP |
|---|---|---|
| Price | $2.13 | $10.55 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | ★ $6.67 | N/A |
| AVG Volume (30 Days) | ★ 641.8K | 133.5K |
| Earning Date | 11-04-2025 | 12-04-2025 |
| Dividend Yield | N/A | ★ 0.99% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.17 |
| Revenue | $21,094,000.00 | ★ $352,712,000.00 |
| Revenue This Year | N/A | $13.56 |
| Revenue Next Year | $66.19 | $2.42 |
| P/E Ratio | ★ N/A | $9.00 |
| Revenue Growth | 3.36 | ★ 17.65 |
| 52 Week Low | $1.22 | $5.28 |
| 52 Week High | $4.02 | $10.99 |
Technical Indicators
Market Signals| Indicator | OABI | KNOP |
|---|---|---|
| Relative Strength Index (RSI) | 64.68 | 58.29 |
| Support Level | $1.90 | $10.13 |
| Resistance Level | $2.15 | $10.89 |
| Average True Range (ATR) | 0.12 | 0.26 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 80.19 | 59.08 |
Price Performance
Historical ComparisonAbout OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About KNOP KNOT Offshore Partners LP
KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.